SEC Form 4 · accession 0001209191-16-152496
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha J. Carter
Officer — Chief Regulatory Officer
Period of report
Nov 28, 2016
Accepted (ET)
Nov 30, 2016 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $29.76 | Nov 28, 2016 | A | 62,947 | A | — | Nov 27, 2026 | Common Stock | 62,947 | 62,947 | D |
Explanation of responses
- F1This option vests and becomes exercisable as to 25% of the underlying shares on November 28, 2017 and the remainder in equal installments on the last day of the 12 consecutive calendar quarters beginning with March 31, 2018 and ending on December 31, 2020.